HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.9
  1. Home
  2. /Compound

Evodenoson

HCID 11627443
New noteNew reactionRequest quotesPrint preview
Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
844873-47-8
Standard SMILES
COC(=O)N1CCC(CC#Cc2nc(N)c3ncn([C@@H]4O[C@H](C(=O)NC5CC5)[C@@H](O)[C@H]4O)c3n2)CC1
InChIKey
SQJXTUJMBYVDBB-RQXXJAGISA-N
Molecular formula
C23H29N7O6
Average molar mass
499.5 g/mol
Monoisotopic mass
499.21793167

Overview

Evodenoson has been used in trials studying the treatment of Open-angle Glaucoma and Ocular Hypertension.

Names & identifiers

Preferred name
Evodenoson
IUPAC
methyl 4-[3-[6-amino-9-[(2R,3R,4S,5S)-5-(cyclopropylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]prop-2-ynyl]piperidine-1-carboxylate
English name
Evodenoson
Molecular formula
C23H29N7O6
Molecular weight
499.52

Names & synonyms

EVODENOSON844873-47-8ATL-313ATL313DE-112ATL 313HZ03U10J2Zmethyl 4-[3-[6-amino-9-[(2R,3R,4S,5S)-5-(cyclopropylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]prop-2-ynyl]piperidine-1-carboxylateDTXSID40233476evodenosonummethyl 4-(3-(6-amino-9-((2R,3R,4S,5S)-5-(cyclopropylcarbamoyl)-3,4-dihydroxyoxolan-2-yl)-9H-purin-2-yl)prop-2-yn-1-yl)piperidine-1-carboxylatemethyl 4-(3-(6-amino-9-((2R,3R,4S,5S)-5-(cyclopropylcarbamoyl)-3,4-dihydroxyoxolan-2-yl)purin-2-yl)prop-2-ynyl)piperidine-1-carboxylate
Show more names
DE1121-Piperidinecarboxylic acid, 4-[3-[6-amino-9-(N-cyclopropyl-β-D-ribofuranuronamidosyl)-9H-purin-2-yl]-2-propyn-1-yl]-, methyl estermethyl 4-(3-(6-amino-9-((2R,3R,4S,5S)-5-(cyclopropylcarbamoyl)-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-2-yl)prop-2-yn-1-yl)piperidine-1-carboxylatemethyl 4-(3-(6-amino-9-((2R,3S,4R,5S)-5-(cyclopropylcarbamoyl)-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-2-yl)prop-2-yn-1-yl)piperidine-1-carboxylate
methyl 4-(3-{6-amino-9-[(2R,3R,4S,5S)-5-(cyclopropylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]-9H-purin-2-yl}prop-2-yn-1-yl)piperidine-1-carboxylateRefChem:139676Atl313, de-112DTXCID40155967Evodenoson [USAN:INN]UNII-HZ03U10J2ZDE 112EVODENOSON [INN]

Properties

Computed structural properties

XLogP
0
Topological polar surface area
178 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
10
Rotatable bonds
6
Heavy atoms
36
Formal charge
0
Complexity
898

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15

Physicochemical properties

Melting point
131.6 · 131.6-134.9 °C
Density
1.67 · 1.67±0.1 g/cm3(Predicted)
form
Solid
pka
12.84 · 12.84±0.70(Predicted)
color
White to off-white
FDA UNII
3 U10J2Z · HZ03U10J2Z

Chemistry & industry

Applications · 1 item

UsesEvodenoson is a selective agonist of the A2A adenosine receptor. Evodenoson’s primary actions include reducing inflammatory responses, decreasing intestinal fluid secretion, edema, tissue damage, and neutrophil infiltration induced by Clostridium difficile toxin A. Evodenoson’s protective effect is achieved by reducing myeloperoxidase (MPO) and adenosine deaminase (ADA) activities, and by lowering the production of tumor necrosis factor-alpha (TNF-α)[1].

Suppliers

Loading…

Open inquiries

Loading…

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
844873-47-8
PubChem CID
11627443
DTXSID
DTXSID40233476
ChEMBL
CHEMBL1950651
UNII
HZ03U10J2Z